Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose oral mass balance study of radiolabeled RO5200628 in healthy male volunteers
NL-OMON34612Active, not recruiting
- Sponsor
- Roche
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of RO5200628 in major depressive disorder (MDD), sponsored by Roche. Primary endpoints: Urinary recovery of total radioactivity and Fecal recovery of total radioactivity. Started Sep 2010; status: active, not recruiting.
02
Drugs
RO5200628
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON34612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34612.